Skip to main content
SpringerLink
Log in
Book cover

The Myelodysplastic Syndromes pp 1–4Cite as

The History of the Myelodysplastic Syndromes

  • Chapter
  • First Online:

Abstract

The concept of the myelodysplastic syndromes (MDS) arose gradually during the twentieth century but depended on a number of seminal earlier discoveries and developments including aniline dye staining of blood cells as introduced by Paul Ehrlich. The MDS have had a multitude of prior names which inhibited comparative research until the publication over the past 30 years of a series of internationally agreed systems of classification which have standardised terminology. Reports of effective treatment have been published only recently but the field holds great promise.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Neumann E (1869) Über die Bedeutung des Knochenmarkes für die Blutbildung. ein Beitrag zue Entwicklungsgeschichte der Blutkörperchen. Arch Heilkd 10:68–102

    Google Scholar 

  2. Tavassoli M (1980) Bone marrow: the seedbed of blood. In: Wintrobe MM (ed) Blood, pure and eloquent. McGraw-Hill, New York, pp 57–79

    Google Scholar 

  3. Ehrlich P (1879) Methodologische Beiträge zur Physiologie und Patholgie der verschiedenen Formen der Leukocyten. Z Klin Med 1:553–560

    Google Scholar 

  4. Ehrlich P (1877) Beitrag zur Kenntnis der Anilinfärbungen und ihrer Verwendung in der mikroskopischen. Technik Arch Mikr Anat 13:263–277

    Article  Google Scholar 

  5. Wintrobe MM (1980) Blood, pure and eloquent. McGraw-Hill, New York

    Google Scholar 

  6. Matsuo T, Tomonaga M, Bennett JM, Kuriyama K, Imanaka F, Kuramoto A, Kamada N, Ichimaru M, Finch SC, Pisciotta AV et al (1988) Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia. Jpn J Clin Oncol 18:91–96

    PubMed  CAS  Google Scholar 

  7. Curie E (1937) Madame Curie. Doubleday, Garden City

    Google Scholar 

  8. Layton DM, Mufti GJ (1986) Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia. Blut 53:423–436

    Article  PubMed  CAS  Google Scholar 

  9. von Leube W (1900) Rapid verlaufende schwere Anämie mit gleichzeitiger leukämischer Veränderung des Blutbildes. Klin Wochenschr 37:85–97

    Google Scholar 

  10. Luzzatto AM (1907) Sull anemia grave megiloblastica sensa reporto ematologica correspondente (anemia pseudoaplastica). Riv Veneta Med Venezia 47:193

    Google Scholar 

  11. Rhoades CP, Barker WH (1938) Refractory anemia: an analysis of one hundred cases. J Am Med Assoc 110:794–796

    Article  Google Scholar 

  12. Bomford RR, Rhodes CP (1941) Refractory anemia. Q J Med 10:175–281

    CAS  Google Scholar 

  13. Sabine JC (1940) A history of the classification of human blood corpuscles. Bull Hist Med 8:696–720, 785–805

    Google Scholar 

  14. Chevallier P, LaMotte M, Umdenstock R (1942) Trois cas d’anémie-leucose benzolique. Le Sang 15:391–405

    Google Scholar 

  15. Hamilton-Paterson JL (1949) Preleukemia anemia. Acta Hematol 2:309–316

    Article  CAS  Google Scholar 

  16. Block M, Jacobson LO, Bethard WF (1953) Preleukemic acute human leukaemia. J Am Med Assoc 152:1018–1028

    Article  PubMed  CAS  Google Scholar 

  17. Björkman SE (1956) Chronic refractory anemia with sideroblastic bone marrow; a study of four cases. Blood 11:250–259

    PubMed  Google Scholar 

  18. Rheingold JJ (1974) Acute leukemia. Its smoldering phase, or leukemia never starts on thursday. J Am Med Assoc 230:985–986

    PubMed  CAS  Google Scholar 

  19. Rheingold JJ, Kaufman R, Adelson E, Lear A (1963) Smoldering acute leukemia. N Engl J Med 268:812–815

    Article  PubMed  CAS  Google Scholar 

  20. Rosenthal DS, Moloney WC (1984) Refractory dysmyelopoietic anemia and acute leukemia. Blood 63:314–318

    PubMed  CAS  Google Scholar 

  21. Cohen JR, Creger WP, Greenberg PL, Schrier SL (1979) Subacute myeloid leukemia: a clinical review. Am J Med 66:959–966

    Article  PubMed  CAS  Google Scholar 

  22. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33:451–458

    Article  PubMed  CAS  Google Scholar 

  23. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189–199

    PubMed  CAS  Google Scholar 

  24. Bennett JM (2000) World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol 72:131–133

    PubMed  CAS  Google Scholar 

  25. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, Thiele J, Vardiman JW (eds) (2008) WHO classification of tumours of the haematopoietic and lymphoid tissues. IARC, Lyon

    Google Scholar 

  26. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellstrom-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937–951

    Article  PubMed  CAS  Google Scholar 

  27. Raskind WH, Tirumali N, Jacobson R, Singer J, Fialkow PJ (1984) Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 63:1318–1323

    PubMed  CAS  Google Scholar 

  28. Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G (1974) Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature 251:437–438

    Article  PubMed  CAS  Google Scholar 

  29. Haase D (2008) Cytogenetic features in myelodysplastic syndromes. Ann Hematol 87:515–526

    Article  PubMed  Google Scholar 

  30. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079–2088

    PubMed  CAS  Google Scholar 

  31. Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 59:425–433

    Article  PubMed  CAS  Google Scholar 

  32. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 74:395–408

    PubMed  CAS  Google Scholar 

  33. Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W (1992) Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6:52–59

    PubMed  CAS  Google Scholar 

  34. Tallman MS, McGuffin RW, Higano CS, Starkebaum G, Collins SJ, Johnston H, Singer JW, Perry DJ, Kunath A (1987) Bone marrow transplantation in a patient with myelodysplasia associated with diffuse eosinophilic fasciitis. Am J Hematol 24:93–99

    Article  PubMed  CAS  Google Scholar 

  35. Vadhan-Raj S, Keating M, LeMaistre A, Hittelman WN, McCredie K, Trujillo JM, Broxmeyer HE, Henney C, Gutterman JU (1987) Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 317:1545–1552

    Article  PubMed  CAS  Google Scholar 

  36. Chitambar CR, Libnoch JA, Matthaeus WG, Ash RC, Ritch PS, Anderson T (1991) Evaluation of continuous infusion low-dose 5-azacytidine in the treatment of myelodysplastic syndromes. Am J Hematol 37:100–104

    Article  PubMed  CAS  Google Scholar 

  37. List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, Rimsza L, Heaton R, Knight R, Zeldis JB (2005) Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med 352:549–557

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Haematology and Medical Oncology and Menzies Research Institute Tasmania, Royal Hobart Hospital, Hobart, TAS, Australia

    Ray M. Lowenthal

Authors
  1. Ray M. Lowenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ray M. Lowenthal .

Editor information

Editors and Affiliations

  1. , 3rd Department of Internal Medicine, Semmelweis University, Kútvölgyi út 4, Budapest, 1125, Hungary

    Judit Várkonyi

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Lowenthal, R. (2011). The History of the Myelodysplastic Syndromes. In: Várkonyi, J. (eds) The Myelodysplastic Syndromes. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0440-4_1

Download citation

Publish with us

Policies and ethics

Search

Navigation